Literature DB >> 2448435

Developmental regulation of ganglioside antigens recognized by the JONES antibody.

B Schlosshauer1, A S Blum, R Mendez-Otero, C J Barnstable, M Constantine-Paton.   

Abstract

The JONES monoclonal antibody has been immunocytochemically associated with regions of the developing rat brain where cell and axon migrations are occurring (Mendez-Otero et al., 1986, 1988). In the present study the antigens recognized by the JONES antibody were analyzed in a variety of brain regions and at developmental ages selected to correspond to the preceding immunocytochemical observations. In accordance with earlier results from retina, JONES binding could not be detected in SDS gels from developing brain. Binding of the antibody was, however, prominent in chloroform/methanol extracts of the same tissues, and it was completely removed from tissue sections by brief chloroform/methanol form/methanol treatment. Enzymatic analyses of chloroform/methanol extracts indicated that the JONES epitope was sensitive to neuraminidase but insensitive to proteases. Overlay assays on developed high-performance thin-layer chromatographic plates (HPTLC) indicate that in all regions the JONES epitope resides on 2 or 3 ganglioside bands, depending on the age examined. These bands migrate between ganglioside standards GD 1a and GM2 on HPTLC plates and have been designated GJ1, GJ2, and GJ3, with the higher number designating the more rapidly migrating species. Occasionally, additional bands migrating in the range of polysialogangliosides were observed. The pattern of expression of GJ species was studied in forebrain, retina, and cerebellar tissue taken from embryonic day 18 (E18), postnatal day 0 (P0), P7, P14, and adult animals. Both region-specific differences in the relative prominence of each band and stage-specific differences in the total amount of the JONES gangliosides were detected. The stage-specific differences in the amount of JONES antigens are well correlated with the developmental periods of maximal cell migration in each region. While the JONES gangliosides are most prominent in forebrain before birth, in they are most prominent during the first 2 postnatal weeks. In cerebellum, JONES antigen expression is more pronounced during the 2 periods of cell migration in this tissue. In retina, the more rapidly migrating GJ3 band was the most prominent band at all stages examined, and this same band is retained in the adult. In cerebellum and forebrain GJ3 is also the most pronounced band during development. However, in contrast to the retina, the more slowly migrating GJ1 band is retained in adult forebrain and cerebellum. A variety of non-brain tissues have also been examined for the presence of the JONES antigens.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448435      PMCID: PMC6569300     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  17 in total

1.  Compartmentation in mammalian cerebellum: Zebrin II and P-path antibodies define three classes of sagittally organized bands of Purkinje cells.

Authors:  N Leclerc; G A Schwarting; K Herrup; R Hawkes; M Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  An anti-invasive concentration of the alkyl-lysophospholipid ET-18-OCH3 enhances the motility of embryonal chick heart cells cultured on solid substrate.

Authors:  N A van Larebeke; E A Bruyneel; M M Mareel
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

3.  Involvement of 9-O-Acetyl GD3 ganglioside in Mycobacterium leprae infection of Schwann cells.

Authors:  Victor Túlio Ribeiro-Resende; Michelle Lopes Ribeiro-Guimarães; Robertha Mariana Rodrigues Lemes; Isis Cristina Nascimento; Lucinéia Alves; Rosalia Mendez-Otero; Maria Cristina Vidal Pessolani; Flávio Alves Lara
Journal:  J Biol Chem       Date:  2010-08-25       Impact factor: 5.157

4.  CDw60: an antigen expressed in many normal tissues and in some tumours.

Authors:  A Gocht; A Gadatsch; G Rutter; B Kniep
Journal:  Histochem J       Date:  2000-07

5.  Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III.

Authors:  Seth H Pincus; Emily Moran; Grace Maresh; Harold J Jennings; David G Pritchard; Marianne L Egan; Ola Blixt
Journal:  Vaccine       Date:  2012-05-23       Impact factor: 3.641

6.  Chemoenzymatic synthesis of GD3 oligosaccharides and other disialyl glycans containing natural and non-natural sialic acids.

Authors:  Hai Yu; Jiansong Cheng; Li Ding; Zahra Khedri; Yi Chen; Sharlene Chin; Kam Lau; Vinod Kumar Tiwari; Xi Chen
Journal:  J Am Chem Soc       Date:  2009-12-30       Impact factor: 15.419

7.  Developmental changes in gangliosides in cultured cerebellar granule neurons.

Authors:  W Thangnipon; R Balázs
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

8.  Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.

Authors:  Jiansong Cheng; Hai Yu; Kam Lau; Shengshu Huang; Harshal A Chokhawala; Yanhong Li; Vinod Kumar Tiwari; Xi Chen
Journal:  Glycobiology       Date:  2008-05-28       Impact factor: 4.313

9.  Isolation and characterization of ganglioside 9-O-acetyl-GD3 from bovine buttermilk.

Authors:  D M Bonafede; L J Macala; M Constantine-Paton; R K Yu
Journal:  Lipids       Date:  1989-08       Impact factor: 1.880

Review 10.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.